Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADXS | ATNM | NBY | ||
| Company | Ayala Pharmaceuticals Inc | Actinium Pharmaceuticals Inc | Novabay Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | OTC US | NYSE Arca | NYSE Arca | ||
| Open | 0.6195 | 1.2300 | 1.2400 | ||
| High | 0.6195 | 1.2300 | 1.3600 | ||
| Low | 0.6000 | 1.1600 | 1.2000 | ||
| Latest | 0.6036 | 1.1800 | 1.2700 | ||
| Change | +0.0336 | -0.0300 | +0.0100 | ||
| % Change | +5.89% | -2.48% | +0.79% | ||
| Volume | 13,500 | 67,600 | 242,800 | ||
| 20-Day Average Volume | 12,970 | 109,575 | 512,095 | ||
| Previous Close | 0.5700 | 1.2100 | 1.2600 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2959 | 1.1335 | 1.9271 | ||
| 20-Day Raw Stochastic | 86.21% | 71.11% | 6.06% | ||
| 20-Day Relative Strength | 64.81 | 48.17 | 38.52 | ||
| Weighted Alpha | +228.41 | -10.07 | -68.92 | ||
| Today's Opinion | 100% Buy | 80% Sell | 40% Sell | ||
| Previous Opinion | 100% Buy | 80% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.01% since 01/23/26 | -4.07% since 03/04/26 | -13.01% since 03/04/26 | ||
| Low | 0.3333 on 01/28/26 | 1.1600 on 03/11/26 | 1.1100 on 03/09/26 | ||
| High | 0.7000 on 01/29/26 | 1.2450 on 03/05/26 | 1.6000 on 03/06/26 | ||
| 1-Month | |||||
| %Chg | +663.08% since 01/02/26 | +5.36% since 02/11/26 | -61.63% since 02/11/26 | ||
| Low | 0.0011 on 01/06/26 | 1.0200 on 02/18/26 | 1.1100 on 03/09/26 | ||
| High | 0.7000 on 01/29/26 | 1.2450 on 03/05/26 | 3.7500 on 02/20/26 | ||
| 3-Month | |||||
| %Chg | +1,081.21% since 11/03/25 | -18.62% since 12/11/25 | -90.96% since 12/11/25 | ||
| Low | 0.0011 on 01/06/26 | 1.0200 on 02/18/26 | 1.1100 on 03/09/26 | ||
| High | 0.7000 on 01/29/26 | 1.7200 on 12/22/25 | 99.7500 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +1,405.24% since 07/28/25 | -29.76% since 09/11/25 | -91.36% since 09/11/25 | ||
| Low | 0.0011 on 01/06/26 | 1.0200 on 02/18/26 | 1.1100 on 03/09/26 | ||
| High | 0.8010 on 08/25/25 | 1.7400 on 10/24/25 | 99.7500 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 35,797 | 36,811 | 32,921 | ||
| Shares Outstanding, K | 59,305 | 31,196 | 25,922 | ||
| Annual Sales | 10,000 | 0 | 9,780,000 | ||
| Annual Net Income | -48,070,000 | -38,240,000 | -7,220,000 | ||
| Last Quarter Sales | 0 | 90,000 | 520,000 | ||
| Last Quarter Net Income | -7,340,000 | -5,130,000 | -1,290,000 | ||
| 60-Month Beta | 1.75 | -0.31 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/10/21 | -0.16 on 11/14/25 | -0.23 on 11/07/25 | ||
| Latest Earnings Date | 02/19/24 | 03/30/26 | 04/01/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||